Alpha Crest Capital Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Alpha Crest Capital Management LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $1.85 Million - $2.34 Million	-3,230 Reduced 63.94%	1,822 $1.26 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $590,572 - $795,730	1,077 Added 27.09%	5,052 $2.99 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $2.26 Million - $2.65 Million	-3,800 Reduced 48.87%	3,975 $2.78 Million
Q4 2021 Feb 09, 2022	BUY	$543.48 - $670.97 $57,065 - $70,451	105 Added 1.37%	7,775 $4.91 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $549,920 - $652,359	958 Added 14.27%	7,670 $4.64 Million
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $204,722 - $241,847	-433 Reduced 6.06%	6,712 $3.75 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $1.41 Million - $1.73 Million	3,159 Added 79.25%	7,145 $3.38 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $1.09 Million - $1.38 Million	2,272 Added 132.56%	3,986 $1.93 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $475,566 - $574,617	873 Added 103.8%	1,714 $959,000
Q2 2020 Aug 12, 2020	SELL	$493.32 - $643.92 $41,438 - $54,089	-84 Reduced 9.08%	841 $524,000
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $216,499 - $318,412	-644 Reduced 41.05%	925 $452,000
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $3.5 Million - $4.81 Million	-12,764 Reduced 89.05%	1,569 $589,000
Q3 2019 Nov 12, 2019	BUY	$273.46 - $318.39 $2.51 Million - $2.92 Million	9,163 Added 177.23%	14,333 $3.98 Million
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $1.55 Million - $2.14 Million	5,170 New	5,170 $1.62 Million

1,484

83.7M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.